4 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    8 4 0 0

Biomedicine and pharmacotherapy
Volume 63, n° 9
pages 619-626 (novembre 2009)
Doi : 10.1016/j.biopha.2008.12.001
Received : 12 November 2008 ;  accepted : 6 December 2008
Gene expression, cytoskeletal changes and extracellular matrix synthesis in human osteoblasts treated with cyclosporin A

Maurizio Vertemati a, Ernesto Minola b, Claudia Dolci a, Giordano Stabellini a, , Furio Pezzetti c, Claudia Moscheni a, Carla Calastrini d, Manuela Bramerio b, Annalisa Palmieri e, Laura Vizzotto a
a Department of Human Morphology, University of Milan, Milan, Italy 
b Department of Pathological Anatomy Niguarda Hospital, Milan, Italy 
c Department of Histology, Embryology and Applied Biology, University of Bologna, Bologna, Italy 
d Department of Morphology and Embryology, Section of Histology and Embryology, University of Ferrara, Ferrara, Italy 
e Maxillofacial Surgery, University of Ferrara, Ferrara, Italy 

Corresponding author. Dipartimento di Morfologia Umana, Via Mangiagalli 31, 20133 Milano, Italy. Tel.: +39 025 031 5393; fax: +39 025 031 5387.

Cyclosporin A (CyA) is an immunosuppressive agent used to prevent allograft rejection, but unfortunately it causes adverse effects such as bone diseases, osteoporosis and osteomalacia. These pathologies involve an imbalance between synthesis, degradation and mineralization of extracellular matrix. CyA can modify extracellular matrix components such as glycosaminoglycans (GAG) and collagen fibers. In addition, normal cell activity is dependent on cell morphology and substrate cell attachment. We treated normal human osteoblasts with CyA and analyzed: (i) gene expression by a microarray method; (ii) extracellular GAG and collagen after 3H-glucosamine and Western blot analysis; and (iii) cytoskeletal changes, using actin and tubulin fluorescent antibodies. CyA increased intra- and extracellular GAG and extracellular GAG classes such as hyaluronic acid, chondroitin sulphate, and dermatan sulphate; there was no noteworthy effect on heparan sulphate and the ratio of non-sulphated to sulphated GAG. In osteoblast cultures the drug reduced cytoskeletal actin, while tubulin did not change. In vivo the osteoblasts showed morphological changes with different extracellular matrix synthesis. Microarray analysis indicated the inhibition of gene pathways related to Wnt signaling molecules, and the cytoskeletal and focal adhesion cascade. In in vitro human osteoblasts CyA modified gene expression related to cytoskeletal pattern organization and cell morphology. Since in bone pathologies osteoblasts show different morphology related to cell size, these data suggest that in vivo osteoblast different functions could be dependent on alteration of osteoblast differentiation.

The full text of this article is available in PDF format.

Keywords : Cyclosporin A, Gene expression, Cytoskeleton

© 2008  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline